Skip to content

B-335 Development of an Isotope-Dilution LC-MRM-MS Method for The Quantification of Serum Anti-Mullerian Hormone

Oct 2026 · Clinical Chemistry · 0 citations

Abstract

Anti-Mullerian hormone (AMH) is a key biomarker for evaluating functional ovarian reserve (FOR), guiding fertility treatments, and assessing reproductive lifespan. Nevertheless, current FDA-cleared assays for serum AMH are poorly correlated. Resolving these inter-assay inconsistencies is crucial for consistent care, especially for monitoring a broad spectrum of FOR-affecting conditions – such as reproductive illnesses, autoimmune diseases, and recovery from cancer treatment. Moreover, serum AMH has been shown to strongly correlate with all three qualitative criteria (Rotterdam criteria) used for the diagnosis of polycystic ovary syndrome (PCOS), indicating the need for a robust method for measuring serum AMH in patients suspected of PCOS. This study presents the development of stable isotope-labeled AMH peptides that will allow for accurate quantification using an isotope-dilution liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) approach. 2 gene blocks encoding 20 tryptic peptides spanning the full-length AMH sequence were cloned into plasmids such that 2 polypeptide concatemers (each containing 10 tryptic peptides and their surrounding sequences lined up head-to-tail) can be recombinantly expressed in budding yeast with affinity tags appended to both N- and C-termini of the concatemers. These concatemers were placed under the control of a CUP1 promoter, enabling inducible expression at high levels upon exposure to copper. The use of a budding yeast expression system allows for the isotope labeling of these concatemers through stable isotope labeling by amino acids in cell culture (SILAC) by heavy arginine (13C6 15N4) and heavy lysine (13C6 15N2). Following the expression and purification of isotope-labeled concatemers, tryptic digests of the concatemers were scouted on a LC-MS/MS system through multiple-reaction monitoring (MRM) to determine optimal quantifier and qualifier ions and establish peptide retention times. The LC method was refined to improve chromatographic consistency and enhance peptide separation, thereby improving cycle times and increasing detection sensitivity. LC optimization was carried out in parallel with optimization of the collision energies (CE) for each transition, which ensures optimal detection sensitivity and stability. LC–MS/MS confirmed the purified concatemers were fully isotope-labeled, with <0.5% cross-contamination between light and heavy forms. The optimized LC gradient resulted in sufficient separation of the 20 AMH peptides, with peptides eluting as early as 0.75 minutes and as late as 3.55 minutes across a 3.75-minute gradient. After CE optimization, signal intensities of the top transition for each peptide spanned >3 orders of magnitude, with product-ion intensities increasing by up to 220-fold; optimized CEs ranged from 10–60 eV, highlighting the importance of CE tuning for robust LC–MS/MS peptide analysis. Preliminary analysis of a patient serum sample containing 11ng/mL of AMH (pre-determined by Roche immunoassay) identified the peptide LVVLHLEETVTWEPTPSLR co-eluting with its spiked stable isotope-labeled analog after a single step of albumin depletion. The presented LC-MRM-MS method is capable of simultaneously monitoring 20 peptides derived from 2 concatemers of AMH peptides. Preliminary analysis of de-identified patient serum samples demonstrated the method’s potential for the identification and quantification of serum AMH with minimal pre-analytical sample preparation. This stable-isotope-labeled concatemer approach provides an alternative to chemically synthesized peptide standards.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.